# Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus

> **NCT00539890** · PHASE3 · COMPLETED · sponsor: **Mannkind Corporation**

## Conditions studied

- Diabetes Type 2

## Interventions

- **DRUG:** Technosphere Insulin

## Key facts

- **NCT ID:** NCT00539890
- **Lead sponsor:** Mannkind Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 0 (—)
- **Last updated:** 2009-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00539890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00539890, "Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00539890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*